|
| Sponsored by: Invest Puerto Rico Puerto Rico offers top-notch talent, tax and R&D incentives, and a robust supply chain, making it a bioscience powerhouse. With the highest concentration of pharma and medical device talent in the U.S., and extensive tax benefits, it’s the perfect destination for innovation.
Stop by Booth 2611 to connect with the Invest Puerto Rico team and learn more about the advantages of investing in Puerto Rico. Our representatives will be available throughout the conference to provide insights, answer questions and discuss opportunities. It's not what's next in bioscience; it's where. Puerto Rico. Learn More. |
|
|
|
| Sponsored by: Integral Molecular Assessment of antibody off-target reactivity is a regulatory requirement for clinical development. However, conventional screening methods, are often ineffective in screening newer therapeutic modalities, and their predictive value for in vivo safety and toxicity is poor.
So, what are the alternatives? Register now for this June 6th webinar to learn about the new, innovative cell-based protein array approach to specificity profiling. |
|
|
|
| Sponsored by: Bio-Techne Cell therapy developers face many challenges as they transition from benchtop to bedside. Utilizing high quality grade reagents and clinic-ready processes earlier in the development pipeline is one good way to futureproof cell therapy development and manufacturing programs.
Download this whitepaper to examine when and how to transition to GMP critical reagents, covering key topics including how to navigate unclear guidance on ancillary cell therapy reagents, advice on how to balance reagent costs and benefits and more. |
|
|
|
| |
|
